Mannkind (MNKD) Prepaid Assets (2010 - 2026)
Mannkind (MNKD) reported Prepaid Assets of $40.0 million for Q1 2026, up 16.25% year-over-year from $34.4 million in Q1 2025, and down 14.09% on a QoQ basis from $46.6 million in Q4 2025.
Mannkind (MNKD) has 17 years of Prepaid Assets data on file, last reported at $40.0 million in Q1 2026.
- Quarterly Prepaid Assets rose 16.25% year-over-year to $40.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $40.0 million (up 16.25% YoY) and the FY2025 annual result came in at $46.6 million, up 48.45% from the prior year.
- Prepaid Assets slipped to $40.0 million in Q1 2026 per MNKD's latest filing, from $46.6 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $54.4 million in Q3 2025 and bottomed at $3.7 million in Q2 2022.
- The 5-year median for Prepaid Assets is $32.8 million (2023), against an average of $30.1 million.
- The widest annual swing landed in 2023, when Prepaid Assets soared 782.62%; it then dropped 12.33% in 2024.
- Tracing MNKD's Prepaid Assets over 5 years: stood at $25.5 million in 2022, then surged by 36.78% to $34.8 million in 2023, then slipped by 10.01% to $31.4 million in 2024, then surged by 48.45% to $46.6 million in 2025, then decreased by 14.09% to $40.0 million in 2026.
- Per Business Quant, the three latest MNKD Prepaid Assets figures stand at $40.0 million (Q1 2026), $46.6 million (Q4 2025), and $54.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.00 Mn |
| Dec 31, 2025 | 46.55 Mn |
| Sep 30, 2025 | 54.45 Mn |
| Jun 30, 2025 | 44.41 Mn |
| Mar 31, 2025 | 34.40 Mn |
| Dec 31, 2024 | 31.36 Mn |
| Sep 30, 2024 | 31.23 Mn |
| Jun 30, 2024 | 30.08 Mn |
| Mar 31, 2024 | 36.02 Mn |
| Dec 31, 2023 | 34.85 Mn |
| Sep 30, 2023 | 35.62 Mn |
| Jun 30, 2023 | 32.81 Mn |
| Mar 31, 2023 | 15.45 Mn |
| Dec 31, 2022 | 25.48 Mn |
| Sep 30, 2022 | 11.57 Mn |
| Jun 30, 2022 | 3.72 Mn |
| Mar 31, 2022 | 3.95 Mn |
| Dec 31, 2021 | 3.48 Mn |
| Sep 30, 2021 | 3.23 Mn |
| Jun 30, 2021 | 3.62 Mn |
| Mar 31, 2021 | 2.77 Mn |
| Dec 31, 2020 | 3.12 Mn |
| Sep 30, 2020 | 4.62 Mn |
| Jun 30, 2020 | 1.86 Mn |
| Mar 31, 2020 | 1.90 Mn |
| Dec 31, 2019 | 2.89 Mn |
| Sep 30, 2019 | 3.58 Mn |
| Jun 30, 2019 | 2.70 Mn |
| Mar 31, 2019 | 2.39 Mn |
| Dec 31, 2018 | 2.56 Mn |
| Sep 30, 2018 | 3.02 Mn |
| Jun 30, 2018 | 2.57 Mn |
| Mar 31, 2018 | 2.35 Mn |
| Dec 31, 2017 | 3.01 Mn |
| Sep 30, 2017 | 3.06 Mn |
| Jun 30, 2017 | 2.56 Mn |
| Mar 31, 2017 | 3.51 Mn |
| Dec 31, 2016 | 4.36 Mn |
| Sep 30, 2016 | 4.53 Mn |
| Jun 30, 2016 | 1.42 Mn |
| Mar 31, 2016 | 2.81 Mn |
| Dec 31, 2015 | 4.02 Mn |
| Sep 30, 2015 | 13.23 Mn |
| Jun 30, 2015 | 14.08 Mn |
| Mar 31, 2015 | 16.38 Mn |
| Dec 31, 2014 | 20.21 Mn |
| Sep 30, 2014 | 20.25 Mn |
| Jun 30, 2014 | 3.70 Mn |
| Mar 31, 2014 | 3.64 Mn |
| Dec 31, 2013 | 5.49 Mn |
| Sep 30, 2013 | 5.23 Mn |
| Jun 30, 2013 | 3.18 Mn |
| Mar 31, 2013 | 3.83 Mn |
| Dec 31, 2012 | 4.52 Mn |
| Sep 30, 2012 | 21.08 Mn |
| Jun 30, 2012 | 18.36 Mn |
| Mar 31, 2012 | 3.00 Mn |
| Dec 31, 2011 | 3.14 Mn |
| Sep 30, 2011 | 2.96 Mn |
| Jun 30, 2011 | 1.59 Mn |
| Dec 31, 2010 | 2.85 Mn |